Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976–2001
Open Access
- 30 January 2007
- Vol. 109 (6), 1174-1182
- https://doi.org/10.1002/cncr.22511
Abstract
BACKGROUND. A hypothesis generated a retrospective analysis of the improvement of survival over time in patients with cutaneous melanoma (CM) in order to identify factors contributing to this progress. METHODS. A cohort of 4791 patients diagnosed with primary CM in southern Germany between 1976 and 2001 was analyzed. Kaplan-Meier analyses were performed to estimate and to compare overall survival (OS) and survival after first recurrence (SAR). The Cox proportional hazards model was used to evaluate the effect of multiple variables on OS and SAR. RESULTS. Diagnosis of primary CM during 1990–2001 compared with 1976–1989 was associated with more favorable 10-year OS (88.6% vs 80.0%, P < .0001). The median tumor thickness at primary diagnosis was significantly lower during the second period (0.75 mm vs 1.07 mm, P < .0001). In the multivariate analysis, adjusted for tumor thickness, ulceration, age, gender, and anatomical site, the period of diagnosis retained its significance as a predictor of OS (P = .002). The SAR was more favorable during the second period in patients who developed their first metastasis in the regional lymph nodes (45.2% vs 32.9%, P = .017) or in distant sites (13.4% vs 2.0%, P = .0002) and this finding persisted in the multivariate analysis. CONCLUSIONS. Improvement of survival of CM patients diagnosed 1990–2001 as compared with 1976–1989 may not be entirely attributable to factors associated with early diagnosis and more favorable primary tumors. Therefore, factors of melanoma management, which changed between the 2 time periods, such as sentinel node biopsy, adjuvant treatment, structured follow-up, and surgical interventions in distant metastasis, may have to be taken into account. Cancer 2007 © 2007 American Cancer Society.Keywords
This publication has 34 references indexed in Scilit:
- Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanomaCancer, 2006
- Sun Exposure and Mortality From MelanomaJNCI Journal of the National Cancer Institute, 2005
- Development of prognostic factors and survival in cutaneous melanoma over 25 yearsCancer, 2005
- Excision Margins in High-Risk Malignant MelanomaNew England Journal of Medicine, 2004
- Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in ScandinaviaInternational Journal of Cancer, 2003
- Does Complete Resection of Melanoma Metastatic to Solid Intra-Abdominal Organs Improve Survival?Annals of Surgical Oncology, 2001
- Sentinel Lymph Node Biopsy for Melanoma: How Many Radioactive Nodes Should be Removed?Annals of Surgical Oncology, 2001
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)Annals of Surgical Oncology, 2000
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the LimbsNew England Journal of Medicine, 1977